EFFICACY AND SAFETY OF TOFACITINIB AFTER FAILURE OF ANTI-TNF AGENT IN PATIENTS WITH ULCERATIVE COLITIS: A US-BASED PROPENSITY MATCHED COHORT STUDY

被引：0
|
作者：
Kochhar, Gursimran S.
Desai, Aakash
Dulai, Parambir S.
Cross, Raymond K.
Farraye, Francis A.
Regueiro, Miguel D.
El-Hachem, Sandra
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1711
引用
收藏
页码：S646 / S647
页数：2
相关论文
共 50 条
  • [11] Does Failure to Respond to One Anti-TNF Agent in Ulcerative Colitis Predict Treatment Failure With Other Anti-TNF Agents
    AlAlawi, Fatema
    Keegan, Denise
    Byrne, Kathryn
    Mulcahy, Hugh
    Cullen, Garret
    Doherty, Glen A.
    GASTROENTEROLOGY, 2015, 148 (04) : S266 - S267
  • [12] Efficacy of Infliximab after failure of subcutaneous anti-TNF agents in patients with moderate-to-severe ulcerative colitis
    Viazis, N.
    Tsoukali, E.
    Galanopoulos, M.
    Pontas, C.
    Karampekos, G.
    Filippidis, G.
    Giouleme, O.
    Theocharis, G.
    Tzouvala, M.
    Archavlis, E.
    Christidou, A.
    Mantzaris, G. J.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S366 - S367
  • [13] Biologics beyond Anti-TNF Agents for Ulcerative Colitis - Efficacy, Safety, and Cost?
    Farrell, Richard J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (13) : 1279 - 1281
  • [14] Durability of a second-line anti-TNFα agent compared to a different mechanism of action after first anti-TNFα failure in ulcerative colitis: CambiaCU Study
    Lopez-Vico, M.
    Hernandez-Martinez, A.
    Soto-Escribano, P.
    Rojas-Feria, M.
    Cornejo-Jimenez, A.
    Caballero-Mateos, A. M.
    Trapero-Martinez, A. M.
    Sanchez-Capilla, A. D.
    Cabello-Tapia, M. J.
    Martin-Rodriguez, M. D. M.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1208 - I1208
  • [15] Effectiveness of a second-line anti-TNFα agent compared to a different mechanism of action after first anti-TNFα failure in ulcerative colitis: CambiaCU Study
    Lopez-Vico, M.
    Hernandez-Martinez, A.
    Soto-Escribano, P.
    Rojas-Feria, M.
    Cornejo-Jimenez, A.
    Caballero-Mateos, A. M.
    Trapero-Martinez, A. M.
    Sanchez-Capilla, A. D.
    Cabello-Tapia, M. J.
    Martin-Rodriguez, M. D. M.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1293 - I1293
  • [16] Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn’s disease: a multicentre retrospective study
    Cassandra Rayer
    Maria Nachury
    Arnaud Bourreille
    Xavier Roblin
    Laurent Peyrin-Biroulet
    Stephanie Viennot
    Mathurin Flamant
    David Laharie
    Bénédicte Caron
    Marie Dewitte
    Laurent Siproudhis
    Mathurin Fumery
    Guillaume Bouguen
    BMC Gastroenterology, 22
  • [17] Risk of Tofacitinib-Related Adverse Events in Patients With Ulcerative Colitis: A Nationwide Propensity-Matched Cohort Study
    Kochhar, Gursimran S.
    Desai, Aakash
    Cross, Raymond
    Farraye, Francis A.
    Hanauer, Stephen B.
    Dulai, Parambir S.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10) : S620 - S621
  • [18] Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn's disease: a multicentre retrospective study
    Cassandra, Rayer
    Nachury, Maria
    Arnaud, Bourreille
    Xavier, Roblin
    Laurent, Peyrin-Biroulet
    Stephanie, Viennot
    Mathurin, Flamant
    David, Laharie
    Benedicte, Caron
    Marie, Dewitte
    Laurent, Siproudhis
    Mathurin, Fumery
    Guillaume, Bouguen
    BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [19] Outcome in ulcerative colitis after switch from subcutaneous anti-TNF to intravenous anti-TNF: A multicentre study
    Viola, A.
    Pugliese, D.
    Renna, S.
    Furfaro, F.
    Caprioli, F.
    D'Inca', R.
    Bossa, F.
    Costantino, G.
    Fantini, M.
    Fiorino, G.
    Armuzzi, A.
    Orlando, A.
    Fries, W.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S418 - S418
  • [20] OUTCOME IN ULCERATIVE COLITIS AFTER SWITCH FROM SUBCUTANEOUS ANTI-TNF TO INTRAVENOUS ANTI-TNF: A MULTICENTRE STUDY
    Viola, A.
    Pugliese, D.
    Renna, S.
    Furfaro, F.
    Caprioli, F.
    D'Inca, R.
    Bossa, F.
    Costantino, G.
    Fantini, M. C.
    Fiorino, G.
    Armuzzi, A.
    Orlando, A.
    Fries, W.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : E193 - E193
12345